
Sanity Group spans medical and consumer cannabis categories; Vayamed distributes medical cannabis medicines to pharmacies and clinical facilities for patients.
sanitygroup.comCrawled Nov 3, 2026
The Sanity Group outlines five cannabis production models, including their advantages and disadvantages.
The Sanity Group’s discussion paper on cannabis legalization proposes an interpretive approach to advertising rules.
The Endlich e.V. initiative aims to destigmatize cannabis use through education and media campaigns.
Organigram Global is consolidating operations by integrating Sanity Group into its unified global structure. The move aims to streamline processes and enhance collaboration across the company’s international teams. This follows Organigram’s expansion strategy to strengthen its global cannabis business operations.
Aug 2026BNN BloombergNews article
Organigram reports a **49% revenue increase** to **CA$105.8 million** in Q3, driven by its acquisition of Sanity Group. The deal expands its international footprint, with global sales now accounting for **35% of total revenue**. The company attributes the growth to the integration of Sanity’s European operations.
Aug 2026MJBizDailyNews article
Organigram Holdings Inc. acquires a minority stake in Sanity Group, a German cannabis company, through a **$21 million investment**. The Moncton-based producer signals potential for further funding, though no additional details are confirmed. Sanity Group operates in Europe’s emerging legal cannabis market.
Jun 2024TownAndCountryToday.comNews article
Berlin-based **Sanity Group** secures **€37.6 million** in Europe’s largest cannabis funding round, led by **British American Tobacco (BAT)**, pushing its total funding to over **€100 million**. The investment signals growing big-tobacco involvement in the cannabis sector, though industry observers raise concerns about potential **conflicts of interest** due to BAT’s existing tobacco operations.
Oct 2022Business of CannabisNews article